Lemonade Inc vs Novartis AG — how do they compare? Lemonade Inc trades at $52.87 (market cap $4.09B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 72.2× Lemonade Inc's market cap, and Novartis AG pays a 3.07% dividend while Lemonade Inc pays none. Which is the better fit depends on your goals.
| LMND | NVS | |
|---|---|---|
Market Cap | $4.09B | $295.37B |
Sector | Financials | Health |
52-Week High | $96.57 | $168.62 |
52-Week Low | $47.38 | $119.31 |
Enterprise Value | $3.95B | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →